Selected article for: "cardiac injury and cohort study"
Author: Saleh, Ahmed; Matsumori, Akira; Abdelrazek, Sherif; Eltaweel, Sara; Salous, Amjad; Neumann, Franz-Josef; Antz, Matthias
Title: Myocardial involvement in coronavirus disease 19
  • Cord-id: hrsqf894
  • Document date: 2020_11_20
    • ID: hrsqf894
    Snippet: BACKGROUND: In late 2019, a cohort of patients presenting with pneumonia of unclear etiology in Wuhan, China, heralded the outbreak of coronavirus disease 19 (COVID-19). Previous severe acute respiratory syndrome (SARS) beta-coronavirus infections have been associated with tachyarrhythmias and signs and symptoms of heart failure. The emergence of SARS coronavirus 2 (SARS-CoV-2), which causes COVID-19, has rapidly developed into a pandemic, and a large number of infected patients have been report
    Document: BACKGROUND: In late 2019, a cohort of patients presenting with pneumonia of unclear etiology in Wuhan, China, heralded the outbreak of coronavirus disease 19 (COVID-19). Previous severe acute respiratory syndrome (SARS) beta-coronavirus infections have been associated with tachyarrhythmias and signs and symptoms of heart failure. The emergence of SARS coronavirus 2 (SARS-CoV-2), which causes COVID-19, has rapidly developed into a pandemic, and a large number of infected patients have been reported to have underlying cardiovascular disease. OBJECTIVE: Since there are only scant published data regarding cardiovascular burden in the wake of viral epidemics, this study aimed to evaluate cardiac involvement in COVID-19. MATERIAL AND METHODS: This prospective cohort study included 40 adult inpatients at two centers in Germany. Adult patients diagnosed with COVID-19 in accordance with World Health Organization (WHO) interim guidance were included in the study, which focused on the potential cardiac involvement of SARS-CoV‑2. It was based on laboratory parameters as well as electro- and echocardiographic values to determine the impact of SARS-CoV‑2 virus on heart tissues. RESULTS: The conducted investigations confirmed the relationship between the presence of acute cardiac injury and COVID-19. CONCLUSION: Myocardial injury and impaired myocardial function due to COVID-19 are common; however, no correlation was established between cardiac laboratory or echocardiographic values and mortality. Cardiovascular monitoring upon COVID-19 infection is crucial to determine the burden of cardiac involvement.

    Search related documents:
    Co phrase search for related documents
    • active case and acute pneumonia: 1, 2, 3, 4, 5, 6, 7, 8
    • active case and acute respiratory infection: 1, 2, 3, 4, 5
    • active case and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute cardiac injury and admission prior: 1
    • acute cardiac injury and liver renal: 1, 2, 3, 4, 5
    • acute cardiac injury and liver renal function: 1
    • acute course and admission prior: 1, 2, 3
    • acute course and liver renal: 1
    • acute pneumonia and admission prior: 1, 2, 3
    • acute pneumonia and liver renal: 1, 2
    • acute pneumonia and liver renal function: 1
    • acute respiratory infection and admission prior: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute respiratory infection and liver renal: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory syndrome and admission prior: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and admit patient: 1
    • acute respiratory syndrome and liver renal: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and liver renal function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • admission prior and liver renal: 1, 2, 3
    • admission prior and liver renal function: 1